Rigel Pharmaceuticals, Inc. (RIGL)
30.90
+0.18
(+0.59%)
USD |
NASDAQ |
Jun 10, 16:00
30.94
+0.04
(+0.13%)
After-Hours: 20:00
Rigel Pharmaceuticals Total Return Price : 30.90 for June 10, 2026
Total Return Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Price Data
| Date | Value |
|---|---|
| June 09, 2026 | 30.72 |
| June 08, 2026 | 30.08 |
| June 05, 2026 | 29.93 |
| June 04, 2026 | 30.25 |
| June 03, 2026 | 30.30 |
| June 02, 2026 | 30.02 |
| June 01, 2026 | 29.86 |
| May 29, 2026 | 30.49 |
| May 28, 2026 | 30.05 |
| May 27, 2026 | 29.48 |
| May 26, 2026 | 29.17 |
| May 22, 2026 | 29.01 |
| May 21, 2026 | 29.19 |
| May 20, 2026 | 28.82 |
| May 19, 2026 | 28.30 |
| May 18, 2026 | 28.61 |
| May 15, 2026 | 29.01 |
| May 14, 2026 | 31.92 |
| May 13, 2026 | 32.13 |
| May 12, 2026 | 29.37 |
| May 11, 2026 | 26.20 |
| May 08, 2026 | 26.04 |
| May 07, 2026 | 26.24 |
| May 06, 2026 | 26.67 |
| May 05, 2026 | 28.09 |
| Date | Value |
|---|---|
| May 04, 2026 | 29.54 |
| May 01, 2026 | 29.40 |
| April 30, 2026 | 28.90 |
| April 29, 2026 | 29.22 |
| April 28, 2026 | 30.56 |
| April 27, 2026 | 30.51 |
| April 24, 2026 | 30.29 |
| April 23, 2026 | 30.72 |
| April 22, 2026 | 30.47 |
| April 21, 2026 | 32.29 |
| April 20, 2026 | 32.49 |
| April 17, 2026 | 32.43 |
| April 16, 2026 | 31.77 |
| April 15, 2026 | 32.06 |
| April 14, 2026 | 31.39 |
| April 13, 2026 | 29.97 |
| April 10, 2026 | 29.20 |
| April 09, 2026 | 30.51 |
| April 08, 2026 | 29.73 |
| April 07, 2026 | 28.73 |
| April 06, 2026 | 27.36 |
| April 02, 2026 | 27.53 |
| April 01, 2026 | 27.50 |
| March 31, 2026 | 27.04 |
| March 30, 2026 | 25.72 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Pfizer Inc. | 25.61 |
| Madrigal Pharmaceuticals, Inc. | 471.38 |
| CytomX Therapeutics, Inc. | 2.905 |
| ACADIA Pharmaceuticals, Inc. | 21.25 |
| Alnylam Pharmaceuticals, Inc. | 291.27 |